Medicare Part D drug Data year 2024 Generic name Source: CMS Part D Prescribers

Erlotinib Hcl

Open in the dashboard

Part D claims

2,884

Prescriptions dispensed, refills included

Drug cost

$2,819,793

Paid at the pharmacy, in all

Prescribers

189

With 11 or more claims of it

In 2024, Medicare Part D recorded 2,884 claims for Erlotinib Hcl from 189 prescribers, at a total drug cost of $2.8 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 36 states and territories
Part D claims for Erlotinib Hcl by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 40 594 $392,142
NY 23 392 $669,950
FL 11 187 $167,623
TX 10 155 $188,477
NJ 9 151 $320,040
NC 6 129 $35,075
MI 8 123 $88,487
GA 6 99 $71,116
IL 7 92 $42,170
MA 6 84 $110,318
PA 6 79 $160,834
PR 4 72 $19,852
OH 5 69 $64,895
AR 5 68 $170,960
LA 3 52 $13,944
The other 21 states and territories
State Prescribers Claims Drug cost
NV 3 51 $18,043
KY 3 46 $22,606
MD 3 39 $62,399
CT 3 39 $9,434
VA 3 38 $25,421
AZ 3 37 $16,561
MN 3 37 $57,590
DC 2 34 $3,759
TN 2 28 $33,844
CO 2 24 $9,787
IA 2 23 $2,734
WI 1 23 $4,160
OR 2 22 $6,310
AL 1 13 $586
AK 1 13 $4,889
SC 1 13 $1,112
VT 1 12 $865
ID 1 12 $3,293
WA 1 12 $2,616
OK 1 11 $13,642
MS 1 11 $4,257

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 9 of 9
Part D claims for Erlotinib Hcl by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 103 1,492 $1,270,361
Medical Oncology 40 647 $763,834
Nurse Practitioner 18 300 $351,044
Physician Assistant 10 161 $110,925
Hematology 6 127 $129,498
Internal Medicine 9 121 $167,277
Specialist 1 13 $785
Obstetrics & Gynecology 1 12 $6,392
Neurology 1 11 $19,677

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Jennifer Tseng Hematology-Oncology FL 61 $38,184 None on record
Mohamed Mohamed Hematology NC 53 $16,534 None on record
Natalia Cherkassky Nurse Practitioner NJ 41 $112,378 None on record
Mark Stoopler Medical Oncology NY 40 $157,222 None on record
Helena Yu Medical Oncology NY 35 $78,836 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Other names for erlotinib hcl

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record